Abbott Case Study Competition

Aim

You are invited to submit case studies that address contemporary issues in the practice of diabetes care, diabetes education and self-management involving the use of either a flash blood glucose monitoring and with ambulatory glucose profile.

ADEA members and healthcare professionals are encouraged to submit case studies and join the competition. The competition is managed and facilitated by ADEA, under consultation with a review panel of experienced endocrinologists and CDEs.

Application is now closed.

This program is financially supported by

IFrame

Podcast : Case Study Competition Tips and Tricks

Hosted by Dr. Ashley Ng, this podcast with Chris Uren, winner of 2019 Abbott Case Study Competition shares tips and tricks on submitting a written case study. He will discuss his experience with the preparation phase, challenges and invaluable takeaways from his own work in the process.

Format

Entries can be submitted in writing via Survey Monkey with a maximum of 1000 words.

Topics for case study submissions

Submitted case studies will include principles of person-centered care (see Appendix) and adhere to the DA’s Language Position Statement while discussing the use of flash glucose monitoring* with ambulatory glucose profile** and addressing all of the following questions:

  1. How has the client’s outcomes (clinical or non-clinical) improved with this technology?
  2. How has the technology been used to make a difference to a client’s quality of life?
  3. How has the technology changed practice for an individual health professional or the diabetes care team?
  4. How has it helped to prevent an adverse event?
  5. What are the challenges clients have found with this technology? What has been done as a consequence?

Definition

* The flash glucose monitoring system utilises a glucose sensor/transmitter and handheld receiver to measure multiple glucose data points from interstitial fluid. The glucose sensor is worn on the arm continuously for 14 days and includes a transmitter to communicate with the handheld glucose device. The handheld glucose receiver is used to manually transfer the data and displays the current glucose level, trend arrow and history of the past 8 hours without the need for capillary glucose testing. The receiver may also be used with capillary blood as an insulin dose advisor, however, calibration with capillary blood is not required.

** The Ambulatory Glucose Profile is a software approach to collating and analysing glucose data. It combines glucose readings from multiple days/weeks of glucose monitoring into a single 24 hour period, featuring statistical information such as average, interquartile and interdecile ranges.

Selection Process

Round 1

Selected by reviewing panel

  1. Reviewers will select the top 10 winning case studies for publication.
  2. Among these 10, authors of the top 4 will be invited to Round 2.

Round 2

The People’s Choice Award will be selected by delegates at the ADC

  1. Top 4 will be invited to present their case studies orally at the Australasian Diabetes Congress (ADC) online event
  2. Delegates will vote for their favourite presentation to find one recipient for the People’s Choice Award for the Best Case Study.
  3. Recipient of People’s Choice Award for the Best Case Study will be announced at the Australasian Diabetes Congress (ADC) online event

Important dates

Prize structure

Top 10

People’s Choice Award

The ultimate award title acknowledging the best case study in the whole competition, selected by delegates at the ADC after the oral presentation of the submitted case studies. Only the top 4 are eligible to be considered for this award.

Reviewing panel

  1. Karen Crawford, Co-Chair of the Case Study Reviewing Panel, Chair of ADEA Course Accreditation and Standards of Practice
  2. Dr Ashley Ng, Co-Chair of the Case Study Reviewing Panel, and Chair of the Twitter Champion Group
  3. Peta Tauchmann, Chair of the ADEA Clinical Practice Committee
  4. Ann Bush, ADEA Board Member
  5. Tracey Tellam, ADEA Board Member
  6. Dr Sue-Lynn Lau, Endocrinologist at Westmead Hospital

Consent process

Applicants must obtain written consent of people with diabetes discussed in the submitted case studies, giving permission that they are happy for the selected case studies to be published via print and/or online by ADEA.

Terms and conditions

  1. Submitted case studies must include any principle(s) of person-centred care and adhere to Diabetes Australia’s Language Position Statements while discussing one of the identified questions.
  2. All written case studies must be completed via SurveyMonkey by the due date.
  3. Parts of the submitted case studies that are over the limit (i.e. from the 1,001st word of the written case study) will not be considered.
  4. Submitted case studies must de-identify details of the person in the case study to ensure confidentiality. This means neither names nor initials, locations mentioned in the submissions, e.g. ‘a 32-year-old woman with newly diagnosed type 1 diabetes attended our health service for …’.
  5. Applicants must obtain consent of people with diabetes discussed in the submitted case studies, giving permission that they are happy for the selected case studies to be published via print and/or online by ADEA. Submitted case studies without matching consents will not be reviewed.
  6. Submitted case studies must follow Vancouver referencing style.
  7. 10 successful applicants will receive registrations to the 2020 Australasian Diabetes Congress (ADC) online event, financially supported by Abbott Diabetes Care.
  8. Recipient of the People’s Choice Award might have their case study published in ADE March 2021.
  9. Members of the Reviewing Panel and members of the Abbott Libre Advisory Committee are not eligible for this competition.
  10. Any adverse events experienced by health professionals or people with diabetes should be reported through to Abbott Diabetes Care’s customer service.

Abbott Case Study Competition

Aim

You are invited to submit case studies that address contemporary issues in the practice of diabetes care, diabetes education and self-management involving the use of either a flash blood glucose monitoring and with ambulatory glucose profile.

ADEA members and healthcare professionals are encouraged to submit case studies and join the competition. The competition is managed and facilitated by ADEA, under consultation with a review panel of experienced endocrinologists and CDEs.

Application is now closed.

This program is financially supported by

IFrame

Podcast : Case Study Competition Tips and Tricks

Hosted by Dr. Ashley Ng, this podcast with Chris Uren, winner of 2019 Abbott Case Study Competition shares tips and tricks on submitting a written case study. He will discuss his experience with the preparation phase, challenges and invaluable takeaways from his own work in the process.

Format

Entries can be submitted in writing via Survey Monkey with a maximum of 1000 words.

Topics for case study submissions

Submitted case studies will include principles of person-centered care (see Appendix) and adhere to the DA’s Language Position Statement while discussing the use of flash glucose monitoring* with ambulatory glucose profile** and addressing all of the following questions:

  1. How has the client’s outcomes (clinical or non-clinical) improved with this technology?
  2. How has the technology been used to make a difference to a client’s quality of life?
  3. How has the technology changed practice for an individual health professional or the diabetes care team?
  4. How has it helped to prevent an adverse event?
  5. What are the challenges clients have found with this technology? What has been done as a consequence?

Definition

* The flash glucose monitoring system utilises a glucose sensor/transmitter and handheld receiver to measure multiple glucose data points from interstitial fluid. The glucose sensor is worn on the arm continuously for 14 days and includes a transmitter to communicate with the handheld glucose device. The handheld glucose receiver is used to manually transfer the data and displays the current glucose level, trend arrow and history of the past 8 hours without the need for capillary glucose testing. The receiver may also be used with capillary blood as an insulin dose advisor, however, calibration with capillary blood is not required.

** The Ambulatory Glucose Profile is a software approach to collating and analysing glucose data. It combines glucose readings from multiple days/weeks of glucose monitoring into a single 24 hour period, featuring statistical information such as average, interquartile and interdecile ranges.

Selection Process

Round 1

Selected by reviewing panel

  1. Reviewers will select the top 10 winning case studies for publication.
  2. Among these 10, authors of the top 4 will be invited to Round 2.

Round 2

The People’s Choice Award will be selected by delegates at the ADC

  1. Top 4 will be invited to present their case studies orally at the Australasian Diabetes Congress (ADC) online event
  2. Delegates will vote for their favourite presentation to find one recipient for the People’s Choice Award for the Best Case Study.
  3. Recipient of People’s Choice Award for the Best Case Study will be announced at the Australasian Diabetes Congress (ADC) online event

Important dates

  • 10 February 2020: Applications open via SurveyMonkey
  • 31 August 2020, midnight: Applications close
  • Early October 2020: Results available
  • 12 November 2020: Case studies presentation at ADC2020
  • 13 November 2020: Announcement of People’s Choice Award for the Best Case Study

Prize structure

Top 10

People’s Choice Award

The ultimate award title acknowledging the best case study in the whole competition, selected by delegates at the ADC after the oral presentation of the submitted case studies. Only the top 4 are eligible to be considered for this award.

  • $5,000 scholarship to attend professional development activities
  • Case study to be published in ADE March 2021

Reviewing panel

  1. Karen Crawford, Co-Chair of the Case Study Reviewing Panel, Chair of ADEA Course Accreditation and Standards of Practice
  2. Dr Ashley Ng, Co-Chair of the Case Study Reviewing Panel, and Chair of the Twitter Champion Group
  3. Peta Tauchmann, Chair of the ADEA Clinical Practice Committee
  4. Ann Bush, ADEA Board Member
  5. Tracey Tellam, ADEA Board Member
  6. Dr Sue-Lynn Lau, Endocrinologist at Westmead Hospital

Consent process

Applicants must obtain written consent of people with diabetes discussed in the submitted case studies, giving permission that they are happy for the selected case studies to be published via print and/or online by ADEA.

Terms and conditions

  1. Submitted case studies must include any principle(s) of person-centred care and adhere to Diabetes Australia’s Language Position Statements while discussing one of the identified questions.
  2. All written case studies must be completed via SurveyMonkey by the due date.
  3. Parts of the submitted case studies that are over the limit (i.e. from the 1,001st word of the written case study) will not be considered.
  4. Submitted case studies must de-identify details of the person in the case study to ensure confidentiality. This means neither names nor initials, locations mentioned in the submissions, e.g. ‘a 32-year-old woman with newly diagnosed type 1 diabetes attended our health service for …’.
  5. Applicants must obtain consent of people with diabetes discussed in the submitted case studies, giving permission that they are happy for the selected case studies to be published via print and/or online by ADEA. Submitted case studies without matching consents will not be reviewed.
  6. Submitted case studies must follow Vancouver referencing style.
  7. 10 successful applicants will receive registrations to the 2020 Australasian Diabetes Congress (ADC) online event, financially supported by Abbott Diabetes Care.
  8. Recipient of the People’s Choice Award might have their case study published in ADE March 2021.
  9. Members of the Reviewing Panel and members of the Abbott Libre Advisory Committee are not eligible for this competition.
  10. Any adverse events experienced by health professionals or people with diabetes should be reported through to Abbott Diabetes Care’s customer service.